Copyright
©The Author(s) 2024.
World J Hepatol. Jun 27, 2024; 16(6): 920-931
Published online Jun 27, 2024. doi: 10.4254/wjh.v16.i6.920
Published online Jun 27, 2024. doi: 10.4254/wjh.v16.i6.920
Univariable | Multivariable1 | |||
Significant necroinflammation | OR, (95%CI) | P value | Adjusted OR, (95%CI) | P value |
Age, yr | ||||
< 40 | Referent | Referent | ||
≥ 40 | 1.29 (0.97, 1.72) | 0.0846 | 1.75 (1.25, 2.44) | 0.001 |
Sex | ||||
Male | Referent | Referent | ||
Female | 0.76 (0.54, 1.06) | 0.1007 | 0.75 (0.52, 1.07) | 0.1098 |
HBeAg | ||||
- | Referent | Referent | ||
+ | 2.36 (1.72, 3.24) | < 0.0001 | 2.55 (1.77, 3.68) | < 0.0001 |
HBV-DNA log10, IU/mL | ||||
< 3 | Referent | Referent | ||
≥ 3 | 0.98 (0.63, 1.53) | 0.9258 | 1.10 (0.67, 1.80) | 0.7017 |
PLT, 109/L | ||||
> 150 | Referent | Referent | ||
≤ 150 | 3.16 (2.14, 4.66) | < 0.0001 | 2.77 (1.83, 4.19) | < 0.0001 |
ALT, U/L | ||||
< ULN | Referent | Referent | ||
≥ ULN | 1.85 (1.38, 2.49) | < 0.0001 | 1.60 (1.15, 2.25) | 0.006 |
Significant fibrosis | OR, (95%CI) | P value | Adjusted OR, (95%CI) | P value |
Age, yr | ||||
< 40 | Referent | Referent | ||
≥ 40 | 1.42 (1.07, 1.87) | 0.0136 | 1.36 (1.00, 1.85) | 0.049 |
Sex | ||||
Male | Referent | Referent | ||
Female | 0.88 (0.65, 1.20) | 0.4272 | 0.97 (0.70, 1.35) | 0.8752 |
HBeAg | ||||
- | Referent | Referent | ||
+ | 1.08 (0.79, 1.47) | 0.6367 | 1.14 (0.80, 1.62) | 0.4734 |
HBV-DNA log10, IU/mL | ||||
< 3 | Referent | Referent | ||
≥ 3 | 0.85 (0.56, 1.31) | 0.4636 | 0.93 (0.58, 1.49) | 0.7537 |
PLT,109/L | ||||
> 150 | Referent | Referent | ||
≤ 150 | 4.30 (2.75, 6.71) | < 0.0001 | 3.92 (2.49, 6.17) | < 0.0001 |
ALT, U/L | ||||
< ULN | Referent | Referent | ||
≥ ULN | 1.27 (0.96, 1.68) | 0.0907 | 1.15 (0.84, 1.59) | 0.3758 |
Significant liver histological changes | OR, (95%CI) | P value | Adjusted OR, (95%CI) | P value |
Age, yr | ||||
< 40 | Referent | Referent | ||
≥ 40 | 1.37 (1.03, 1.82) | 0.0308 | 1.44 (1.06, 1.97) | 0.0214 |
Sex | ||||
Male | Referent | Referent | ||
Female | 0.97 (0.71, 1.33) | 0.8423 | 1.05 (0.76, 1.47) | 0.7551 |
HBeAg | ||||
- | Referent | Referent | ||
+ | 1.41 (1.03, 1.95) | 0.0347 | 1.40 (0.97, 2.01) | 0.0689 |
HBV-DNA log10, IU/mL | ||||
< 3 | Referent | Referent | ||
≥ 3 | 0.97 (0.63, 1.49) | 0.8813 | 1.13 (0.70, 1.81) | 0.626 |
PLT,109/L | ||||
> 150 | Referent | Referent | ||
≤ 150 | 3.34 (2.09, 5.35) | < 0.0001 | 2.99 (1.85, 4.83) | < 0.0001 |
ALT, U/L | ||||
< ULN | Referent | Referent | ||
≥ ULN | 1.57 (1.19, 2.09) | 0.0016 | 1.48 (1.08, 2.05) | 0.0163 |
- Citation: Huang DL, Cai QX, Zhou GD, Yu H, Zhu ZB, Peng JH, Chen J. Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase. World J Hepatol 2024; 16(6): 920-931
- URL: https://www.wjgnet.com/1948-5182/full/v16/i6/920.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i6.920